A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced that ...

REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced ...

During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

Learn more about whether Corcept Therapeutics Incorporated or Novartis AG is a better investment based on AAII's A+ Investor ...

Taxpayer dollars shouldn’t be used to fund facilities that choose to profit off abortion,” said John Bursch, a lawyer with ...

Association with oral cavity cancer stronger when restricted to nonsmokers or light smokers and nondrinkers and light drinkers.

Local oncology practice opens new location to provide enhanced cancer care to the Kansas City community.KANSAS CITY, Kan., ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...